Automated workflow enhancements and clinical applications for the Aquilion CT line are designed to reduce patient radiation dose, provide faster diagnosis and maximize patient comfort.

This case is a routine coronary CTA with the focus on the coronary arteries. The patient was a middle-aged male with a family history of coronary artery disease, moderate risk profile and atypical chest pain. The EKG did not indicate myocardial ischemia and there was no enzyme leak.

October 3, 2008 - A Swedish study shows patients transported with ambulance due to ST-elevation myocardial infarction (STEMI), there was a significant association between early recognition and treatment followed by fast tracking to a coronary care unit (CCU) and long-term survival.

October 3, 2008 - Sadra Medical today said the enrollment and treatment of four new patients in the second phase of its European Feasibility Study of the Sadra Lotus Aortic Heart Valve System.

The system is designed to enable physicians to replace a diseased aortic valve utilizing a less invasive approach, navigating the valve through the patient’s arteries using a catheter-based delivery system and thereby eliminating the need for an open chest surgical procedure.

October 2, 2008 - ZOLL Medical Corp. said today the Kuopio University Hospital (KUH), one of the largest hospitals in Finland, successfully implemented the AutoPulse Non-invasive Cardiac Support Pump in its intensive care department.

KUH is the first hospital in Finland to establish protocols for using the AutoPulse. Jouni O. Kurola, M.D., department of anesthesiology and intensive care, KUH, recommended the implementation following a successful evaluation of an AutoPulse provided to the hospital by ZOLL.

October 2, 2008 - Wireless medical technology company CardioNet Inc. today released its new atrial fibrillation (AF) reporting package to enhance its current AF management program.

The CardioNet AF Management Program offers a comprehensive tool to the physician for the diagnosis, treatment and management of their AF patients. The program provides physicians with a flexible monitoring program to evaluate the clinical efficacy of catheter and surgical ablation procedures allowing improved management of these post surgical patients.

October 2, 2008 - The Impact of Sex and Vascular Diseases and Implications for Therapies symposium conducted in February at Cedars-Sinai Medical Center in Los Angeles uncovered a series of knowledge gaps related to the sex differences in vascular disease, its symptoms, risk factors and response to treatment.

Accumetrics will feature its VerifyNow System at TCT 2008, including its comprehensive suite of assays so physicians can assess their patient’s response to antiplatelet therapy in five minutes or less using whole blood, closed tube samples and with no pipetting or sample preparation required.

Unlike statins, antihypertensives, anticoagulants, and other critical therapies, antiplatelet medications are given with the assumption that all patients respond equally, but they do not. Up to one third of patients on antiplatelet medications may not receive the expected inhibiting effect.

October 1, 2008 - Boston Scientific Corp. said today the U.S. District Court in Delaware has entered judgment against the company in a case involving a patent owned by Johnson & Johnson and Boston Scientific’s NIR stent product.

In the judgment, the judge awarded Johnson & Johnson damages in the amount of $406.7 million and pre-judgment interest in the amount of $296.1 million.

Boston Scientific said it will appeal the judgment.

October 1, 2008 - Abiomed Inc. recently completed shipment of its Impella 2.5 Cardiac Assist Device to its 100th U.S. hospital following its June 2008 FDA clearance for partial circulatory support for periods up to six hours.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now